Know Cancer

or
forgot password

Initiating Phase II-III Study to Evaluate the Technique and Effects of Separating the Prostate From the Rectum With Hyaluronic Acid During Radiotherapy


Phase 2/Phase 3
18 Years
75 Years
Open (Enrolling)
Male
Prostatic Cancer

Thank you

Trial Information

Initiating Phase II-III Study to Evaluate the Technique and Effects of Separating the Prostate From the Rectum With Hyaluronic Acid During Radiotherapy


Inclusion Criteria:



- Histologically verified prostatic cancer

- Low or intermediate risk prostatic cancer

- Lymph node negative

- Suitable for radiotherapy

Exclusion Criteria:

- Earlier treatment for prostatic cancer

- Unable to co-operate or suffering from any other form of disease that would interfere
with the planned treatment

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Remaining volume of HA

Outcome Description:

Measurement on the remaining volume of HA by MRI

Outcome Time Frame:

24 month after end of radiotherapy

Safety Issue:

Yes

Principal Investigator

Anders Widmark, Prof MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Umea university, dept of oncology

Authority:

Sweden: Medical Products Agency

Study ID:

NoHarm1

NCT ID:

NCT01787630

Start Date:

January 2010

Completion Date:

December 2014

Related Keywords:

  • Prostatic Cancer
  • Prostatic cancer
  • Radiotherapy
  • Hyaluronic acid
  • Prostatic Neoplasms

Name

Location